Bioequivalence Study of Two Formulations That Contain Isotretinoin 20 mg Capsules in Healthy Colombian Volunteers

4 páginas

Autores:
Vargas Malagón, Mauricio
Villarraga E.
Batista M.
Montenegro L.
Mantilla P.
Tipo de recurso:
Fecha de publicación:
2016
Institución:
Universidad de la Sabana
Repositorio:
Repositorio Universidad de la Sabana
Idioma:
eng
OAI Identifier:
oai:intellectum.unisabana.edu.co:10818/36771
Acceso en línea:
https://www.longdom.org/open-access/bioequivalence-study-of-two-formulations-that-contain-isotretinoin-20mg-capsules-in-healthy-colombian-volunteers-jbb-1000308.pdf
http://hdl.handle.net/10818/36771
Palabra clave:
Bioequivalence
Isotretinoin
Acne
Bioavailability
Pharmacokinetic
Rights
License
Attribution-NonCommercial-NoDerivatives 4.0 International
id REPOUSABA2_2819ecd97027b23e1c3c26bc3276301f
oai_identifier_str oai:intellectum.unisabana.edu.co:10818/36771
network_acronym_str REPOUSABA2
network_name_str Repositorio Universidad de la Sabana
repository_id_str
dc.title.es_CO.fl_str_mv Bioequivalence Study of Two Formulations That Contain Isotretinoin 20 mg Capsules in Healthy Colombian Volunteers
title Bioequivalence Study of Two Formulations That Contain Isotretinoin 20 mg Capsules in Healthy Colombian Volunteers
spellingShingle Bioequivalence Study of Two Formulations That Contain Isotretinoin 20 mg Capsules in Healthy Colombian Volunteers
Bioequivalence
Isotretinoin
Acne
Bioavailability
Pharmacokinetic
title_short Bioequivalence Study of Two Formulations That Contain Isotretinoin 20 mg Capsules in Healthy Colombian Volunteers
title_full Bioequivalence Study of Two Formulations That Contain Isotretinoin 20 mg Capsules in Healthy Colombian Volunteers
title_fullStr Bioequivalence Study of Two Formulations That Contain Isotretinoin 20 mg Capsules in Healthy Colombian Volunteers
title_full_unstemmed Bioequivalence Study of Two Formulations That Contain Isotretinoin 20 mg Capsules in Healthy Colombian Volunteers
title_sort Bioequivalence Study of Two Formulations That Contain Isotretinoin 20 mg Capsules in Healthy Colombian Volunteers
dc.creator.fl_str_mv Vargas Malagón, Mauricio
Villarraga E.
Batista M.
Montenegro L.
Mantilla P.
dc.contributor.author.none.fl_str_mv Vargas Malagón, Mauricio
Villarraga E.
Batista M.
Montenegro L.
Mantilla P.
dc.subject.es_CO.fl_str_mv Bioequivalence
Isotretinoin
Acne
Bioavailability
Pharmacokinetic
topic Bioequivalence
Isotretinoin
Acne
Bioavailability
Pharmacokinetic
description 4 páginas
publishDate 2016
dc.date.issued.none.fl_str_mv 2016
dc.date.available.none.fl_str_mv 2019-08-22T17:14:06Z
dc.date.accessioned.none.fl_str_mv 8/22/2019 12:14
dc.type.en.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.hasVersion.es_CO.fl_str_mv publishedVersion
dc.identifier.citation.es_CO.fl_str_mv Vargas M, Villarraga E, Batista M, Montenegro L, Mantilla P (2016) Bioequivalence Study of Two Formulations That Contain Isotretinoin 20 mg Capsules in Healthy Colombian Volunteers. J Bioequiv Availab 8: 274-277. doi: 10.4172/jbb.1000308
dc.identifier.other.none.fl_str_mv https://www.longdom.org/open-access/bioequivalence-study-of-two-formulations-that-contain-isotretinoin-20mg-capsules-in-healthy-colombian-volunteers-jbb-1000308.pdf
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10818/36771
dc.identifier.doi.none.fl_str_mv 10.4172/jbb.1000308
identifier_str_mv Vargas M, Villarraga E, Batista M, Montenegro L, Mantilla P (2016) Bioequivalence Study of Two Formulations That Contain Isotretinoin 20 mg Capsules in Healthy Colombian Volunteers. J Bioequiv Availab 8: 274-277. doi: 10.4172/jbb.1000308
10.4172/jbb.1000308
url https://www.longdom.org/open-access/bioequivalence-study-of-two-formulations-that-contain-isotretinoin-20mg-capsules-in-healthy-colombian-volunteers-jbb-1000308.pdf
http://hdl.handle.net/10818/36771
dc.language.iso.es_CO.fl_str_mv eng
language eng
dc.relation.ispartofseries.none.fl_str_mv J Bioequiv Availab 2016, 8:6
dc.rights.*.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
http://purl.org/coar/access_right/c_abf2
dc.format.es_CO.fl_str_mv application/pdf
dc.publisher.es_CO.fl_str_mv Journal of Bioequivalence & Bioavailability
dc.source.es_CO.fl_str_mv Universidad de La Sabana
Intellectum Repositorio Universidad de La Sabana
institution Universidad de la Sabana
bitstream.url.fl_str_mv https://intellectum.unisabana.edu.co/bitstream/10818/36771/2/license_rdf
https://intellectum.unisabana.edu.co/bitstream/10818/36771/3/license.txt
bitstream.checksum.fl_str_mv 4460e5956bc1d1639be9ae6146a50347
f52a2cfd4df262e08e9b300d62c85cab
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Intellectum Universidad de la Sabana
repository.mail.fl_str_mv contactointellectum@unisabana.edu.co
_version_ 1811952200631451648
spelling Vargas Malagón, MauricioVillarraga E.Batista M.Montenegro L.Mantilla P.8/22/2019 12:142019-08-22T17:14:06Z2016Vargas M, Villarraga E, Batista M, Montenegro L, Mantilla P (2016) Bioequivalence Study of Two Formulations That Contain Isotretinoin 20 mg Capsules in Healthy Colombian Volunteers. J Bioequiv Availab 8: 274-277. doi: 10.4172/jbb.1000308https://www.longdom.org/open-access/bioequivalence-study-of-two-formulations-that-contain-isotretinoin-20mg-capsules-in-healthy-colombian-volunteers-jbb-1000308.pdfhttp://hdl.handle.net/10818/3677110.4172/jbb.10003084 páginasThis is a pharmacokinetic test of two formulations that contain 20 mg of Isotretinoin, with the aim to compare the bioavailability between the Test Product (Isoface® from Procaps Laboratory SA, Colombia) and the Reference Product (Roaccutane® from Catalent Laboratory Germany, Eberbach GMBH, Germany), to declare the bioequivalence between both formulations. An open, crossed study was developed, randomized, of two periods and two sequences, with 40 mg single dose of isotretinoin, on fasting conditions, on 24 healthy male Colombian volunteers; the washout was 14 days in between each period. To present the results, curves of the plasma concentration ratio vs. Time until hour 72 were performed; with the aim to identify the concentration provided by the Test formulation, the basal status of each volunteer was eliminated from the analysis, which was built with 3 former concentrations to the test medicine administration. The analytical method used in this study was high resolution liquid chromatography with tandem mass spectrometry detector, HPLC MS/MS, for plasma Isotretinoin identification and quantification. The main pharmacokinetic parameters for the Test Product vs. the Reference Product were Tmáx 2.6 vs. 2.8 h, Cmáx 190.5 vs. 186.5 ng/mL for the AUC0-t 3003.8 vs. 2933.5 h* ng/mL and AUC0-∞ 3726.3 vs. 3521.2 h* ng/mL. The confidence interval calculation of data with logarithmic transformation, showed confidence intervals for the variables Tmáx, Cmáx, AUCo-t and AUCo-∞, with values between 80-125; values approved by the FDA and EMA European Medicines Agency, in their Bioavailability and Bioequivalence Guides, to accept the Bioequivalence hypothesis between the two formulations in study, and thereby declare Bioequivalence and interchange ability of the Test Product from Procaps Laboratory, with the Reference Product from Roche Laboratoryapplication/pdfengJournal of Bioequivalence & BioavailabilityJ Bioequiv Availab 2016, 8:6Attribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/http://purl.org/coar/access_right/c_abf2Universidad de La SabanaIntellectum Repositorio Universidad de La SabanaBioequivalenceIsotretinoinAcneBioavailabilityPharmacokineticBioequivalence Study of Two Formulations That Contain Isotretinoin 20 mg Capsules in Healthy Colombian VolunteersarticlepublishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805https://intellectum.unisabana.edu.co/bitstream/10818/36771/2/license_rdf4460e5956bc1d1639be9ae6146a50347MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-8498https://intellectum.unisabana.edu.co/bitstream/10818/36771/3/license.txtf52a2cfd4df262e08e9b300d62c85cabMD5310818/36771oai:intellectum.unisabana.edu.co:10818/367712023-03-10 18:26:55.969Intellectum Universidad de la Sabanacontactointellectum@unisabana.edu.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